Raykov Rosty 4

What Happened
Director Raykov Rosty exercised stock options under a 10b5-1 plan and sold shares. On March 2, 2026 he exercised options for 15,598 shares at $2.45 per share (total exercise cost $38,215) and the filing shows those exercised shares were disposed in connection with the exercise. On the same day he also sold 10,079 shares in an open‑market transaction at $8.36 per share for proceeds of $84,260. Separately, on February 28, 2026, 5,208 restricted shares were released to him (no purchase price).

Key Details

• Filing date: March 3, 2026; reporting period includes transactions dated Feb 28 and Mar 2, 2026. No late‑filing flag indicated in the provided filing.
• Option exercise: 15,598 shares exercised @ $2.45 = $38,215 (transactions executed pursuant to a 10b5‑1 plan adopted Sept 19, 2025). (Footnotes F1, F4)
• Sales: 10,079 shares sold open market @ $8.36 = $84,260. The filing also shows 15,598 exercised shares were disposed/surrendered in connection with the exercise (footnote F2 indicates shares were sold to satisfy tax obligations).
• Award release: 5,208 shares released from restrictions (no cash cost) — these are from prior awards dated 3/31/2023 and 5/16/2024 (footnote F3).
• Shares owned after the transactions: not specified in the supplied summary of the filing.

Context

• The options were exercised under a pre‑arranged 10b5‑1 plan; part or all of the exercised shares were surrendered/sold to satisfy tax withholding (a common, non‑informational administrative step).
• The open‑market sale generated cash proceeds; sales do not necessarily signal negative views by the insider (they can reflect tax, diversification, or liquidity needs).
• For retail investors: purchases (not present here) typically carry more direct bullish signal than routine exercises/sales; this filing primarily documents an exercise plus tax‑related/scheduled sales and a release of vested shares.